These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 16245770

  • 1. [Finely adjusted differential therapy succeeds this way! References for dose adjustments in heart failure (interview by Dr. Dirk Einecke)].
    Erdmann E.
    MMW Fortschr Med; 2005 Sep 29; 147(39):11. PubMed ID: 16245770
    [No Abstract] [Full Text] [Related]

  • 2. [Hyperkalemia, heart failure and reduced renal function].
    Bugge JF.
    Tidsskr Nor Laegeforen; 2010 Jul 01; 130(13):1354-5. PubMed ID: 20596118
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of heart failure. 2 neurohormone blockers are enough].
    MMW Fortschr Med; 2002 Sep 05; 144(35-36):57. PubMed ID: 12380364
    [No Abstract] [Full Text] [Related]

  • 4. [New prospects in diagnosis and treatment of heart failure].
    Pfister U, Lerch R, Hess OM.
    Praxis (Bern 1994); 2002 Jan 30; 91(5):177-80. PubMed ID: 11865776
    [No Abstract] [Full Text] [Related]

  • 5. [How is catecholamine therapy carried out in heart failure?].
    Reek S.
    Dtsch Med Wochenschr; 2002 Oct 04; 127(40):2087-8. PubMed ID: 12373645
    [No Abstract] [Full Text] [Related]

  • 6. Implications of heart failure drug trials: COMET, CHARM, EPHESUS.
    Hiestand B, Abraham WT.
    Rev Cardiovasc Med; 2005 Oct 04; 6 Suppl 2():S4-11. PubMed ID: 15891699
    [Abstract] [Full Text] [Related]

  • 7. [Therapy of heart failure. Which patients does the AT1 blocker help?].
    Böhm M.
    MMW Fortschr Med; 2003 Sep 18; 145(38):8. PubMed ID: 14603671
    [No Abstract] [Full Text] [Related]

  • 8. [Drug therapy in chronic heart failure].
    Airaksinen J, Luomanmäki K.
    Duodecim; 1997 Sep 18; 113(10):965-71. PubMed ID: 11466831
    [No Abstract] [Full Text] [Related]

  • 9. Role of neurohormonal modulators in heart failure with relatively preserved systolic function.
    Rapp JA, Gheorghiade M.
    Cardiol Clin; 2008 Feb 18; 26(1):23-40, vi. PubMed ID: 18312903
    [Abstract] [Full Text] [Related]

  • 10. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep 29; 147(39):10. PubMed ID: 16245769
    [No Abstract] [Full Text] [Related]

  • 11. Traditional and novel approaches to management of heart failure: successes and failures.
    Anand IS, Florea VG.
    Cardiol Clin; 2008 Feb 29; 26(1):59-72, vi. PubMed ID: 18312906
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitors or beta-blockers in heart failure: does it matter who goes first?
    Fang JC.
    Circulation; 2005 Oct 18; 112(16):2380-2. PubMed ID: 16230494
    [No Abstract] [Full Text] [Related]

  • 13. Therapy with ACE inhibitors and ARBs in heart failure.
    Cayley WE.
    Am Fam Physician; 2004 Jul 15; 70(2):261. PubMed ID: 15291087
    [No Abstract] [Full Text] [Related]

  • 14. [Drug treatment of heart failure].
    Kettunen R.
    Duodecim; 2005 Jul 15; 121(11):1239-48. PubMed ID: 15999983
    [No Abstract] [Full Text] [Related]

  • 15. [Should beta-adrenergic blockade be part of drug therapy for heart failure?].
    Leinonen H.
    Duodecim; 1995 Jul 15; 111(3):209-13. PubMed ID: 8654281
    [No Abstract] [Full Text] [Related]

  • 16. Aldosterone antagonists - revisited.
    Sathyamurthy I, Jayanthi K.
    J Assoc Physicians India; 2001 Sep 15; 49():904-6. PubMed ID: 11837759
    [No Abstract] [Full Text] [Related]

  • 17. Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
    Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.
    Am J Med; 2007 Dec 15; 120(12):1090.e1-8. PubMed ID: 18060931
    [Abstract] [Full Text] [Related]

  • 18. [Is it always necessary to use triple combination in the treatment of patients with chronic cardiac failure? Choice of the third neurohormonal blocker].
    Belenkov IuN, Mareev VIu, Skvortsov AA.
    Ter Arkh; 2008 Dec 15; 80(9):5-12. PubMed ID: 19555028
    [No Abstract] [Full Text] [Related]

  • 19. Heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs?
    Parwani P, Ryan J.
    Circ Heart Fail; 2012 Nov 15; 5(6):819. PubMed ID: 23170021
    [No Abstract] [Full Text] [Related]

  • 20. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G, Gorini M, Maggioni AP, Di Lenarda A, Area Scompenso ANMCO, Firenze.
    G Ital Cardiol (Rome); 2007 Feb 15; 8(2):102-6. PubMed ID: 17402354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.